NDATOPICALLOTION
Approved
Dec 1992
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 3d ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SHADE UVAGUARD is a topical sunscreen lotion combining three UV filters (avobenzone, octinoxate, and oxybenzone) to provide broad-spectrum ultraviolet protection. It is indicated for sun protection and prevention of sunburn in general populations. The combination of UV absorbers works by absorbing and dissipating UV radiation across UVA and UVB spectra.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30%), signaling potential team restructuring or portfolio rationalization focus.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on SHADE UVAGUARD offers limited career expansion given its approaching LOE, mature market position, and declining linked job postings. Roles focus on defensive commercial strategies, cost optimization, and transition planning rather than growth initiatives.
Brand ManagerProduct Manager
Worked on SHADE UVAGUARD at Bayer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.